News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Saadvik Raghuram Y: FDA Approves Talectrectinib for ROS1-Positive Locally Advanced or Metastatic NSCLC
Saadvik Raghuram Y/LinkedIn
Jun 25, 2025, 20:47

Saadvik Raghuram Y: FDA Approves Talectrectinib for ROS1-Positive Locally Advanced or Metastatic NSCLC

Saadvik Raghuram Y, Head of Department of Medical Oncology at Arete Hospitals, shared a post on X:

“FDA approves Talectrectinib for ROS1-positive locally advanced or metastatic NSCLC.
  • Response rates in TKI naive (85-90%)
  • ORR in patients with prior TKI (52%)
  • CNS response rates in TKI Naive (73%), prior TKI (63%)
  • Watch out for Dizziness, QTc”

Read further.

Talectrectinib

More posts featuring Saadvik Raghuram Y on OncoDaily.

cancer FDA NSCLC OncoDaily Oncology ROS1-Positive NSCLC Saadvik Raghuram Y talectrectinib
Special Coverage
Blog
Aug 6, 2025, 03:35
Irene Ganan-Gomez: Hematopoietic Stem Cell Hierarchies as Biomarkers of Drug Response in MDS and AML
Blog
Aug 6, 2025, 03:19
Mohammed Ibrahim: A Key Step Towards Launching Our Radiotherapy Services
Radiotherapy
Aug 5, 2025, 23:32
New RT Paper Alert: No Survival Benefit for Zalutumumab in Head And Neck Cancer
Blog
Aug 5, 2025, 20:55
Niranjala Siriwardena: When Hospitals Offer Compassion, Workplaces Offer HR Meetings
Blog
Aug 5, 2025, 20:43
Niranjala Siriwardena: Rewriting What Survivorship Looks Like in Australia and Beyond
Blog
Aug 5, 2025, 20:19
Niranjala Siriwardena: Australia Still Has No Workplace Cancer Survivorship Policy
Blog
Aug 5, 2025, 20:02
Voice of the Families: Mumbere’s Journey with Burkitt Lymphoma - CANCaRe Africa
Insight
Aug 5, 2025, 19:53
Maud Maillard: How NUDT5 Regulates Thiopurine Metabolism in Children with Leukemia?
Science
Aug 5, 2025, 19:50
Nicola Fusco: How Reliable Is ESR1 Mutation Testing in Liquid Biopsy for ER+/HER2- mBC?
Science
Aug 5, 2025, 19:24
Miguel Bronchud: Underestimation of Risk by Biopsies Alone Could Lead to Undertreatment in Prostate Cancer
Blog
Aug 5, 2025, 19:11
Miriam Mutebi: What Legacy Truly Means for African Leadership in Cancer Care
Insight
Aug 5, 2025, 18:55
Svetlana Nikic: Women Leading the Next Era of Cancer Care